GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 14,364 | 13,576 | 21,257 | 57,515 | 6,764 |
| Operating Income | -14,364 | -13,576 | -21,257 | -57,515 | -6,764 |
| Interest Expense | 0 | 213 | 8 | 718 | 3,003 |
| Other Income | 1,202 | 6,192 | 381 | 220 | -18,529 |
| Pre-tax Income | -13,162 | -7,597 | -20,884 | -58,013 | -28,296 |
| Net Income Continuous | -13,162 | -7,597 | -20,884 | -58,013 | -28,296 |
| Net Income | $-13,162 | $-7,597 | $-20,884 | $-58,013 | $-28,296 |
| EPS Basic Total Ops | -6.94 | -5.64 | -19.66 | -61.86 | -193.69 |
| EPS Basic Continuous Ops | -6.94 | -5.64 | -19.66 | -61.88 | -193.78 |
| EPS Diluted Total Ops | -6.94 | -5.64 | -19.66 | -61.86 | -193.69 |
| EPS Diluted Continuous Ops | -6.94 | -5.64 | -19.66 | -61.88 | -193.78 |
| EPS Diluted Before Non-Recurring Items | -6.94 | -5.64 | -19.82 | -61.86 | -193.69 |
| EBITDA(a) | $-14,364 | $-13,576 | $-21,257 | $-57,515 | $-6,447 |